Curated by Vinod Kumar Jain & Amit Jain · All Frontier Global · free, no login · reviewed 2026-07-05
Alpine majesty and precision beauty
The India-EFTA Trade and Economic Partnership Agreement, in force since October 2025, is now in its implementation phase, India's Commerce Secretary visited Switzerland in May 2026 to convert the deal's headline terms, including a pledged $100 billion in EFTA investment into India over 15 years, into actual pharmaceutical, precision-engineering and medtech projects. Indian exports to Switzerland crossed $1.2 billion in FY2025-26, while Swiss pharma and machine-tool investment interest is described as strengthening in early implementation reviews. TEPA is India's first FTA with a bloc of advanced European economies, making Switzerland the test case for whether tariff concessions translate into real Swiss capital on the ground.
Cowbells echo up flawless green valleys, trains climb impossibly into the Alps on time, and fondue steams in pine-panelled mountain huts.
Trade agreements (35): EFTA member; the India–EFTA TEPA is IN FORCE, tying tariff cuts to a ~$100bn EFTA investment pledge into India over 15 years.
Passport strength: visa-free/VOA to ~188 destinations. Swiss passport; visa-free or visa-on-arrival to ~188 countries.
India × Switzerland hub ↗ All countries factsheet
90 days per 180 (Schengen); varies by nationality
e-Visa: no · Visa on arrival: No (Schengen)
Punctual trains, cable cars and funiculars; the Swiss Travel Pass covers most transit.
Car vs taxi: Transit is excellent — skip a car in cities; rent only for scenic Alpine drives.
Money: Cards and contactless widely accepted; some cash useful in villages.
SIM & data: Local SIMs (Swisscom, Sunrise, Salt) are pricier; eSIM is convenient.
Tipping: Not obligatory as service is included; round up for excellent service.
Etiquette: Punctuality is essential; greet with a handshake; keep noise low in public.
Food: Try fondue, raclette and Swiss chocolate; tap water is safe and excellent.
Say hello: German / French / Italian — “Grüezi / Bonjour” · thanks “Danke / Merci” · how much? “Wie viel kostet das?”
Extremely safe; main risks relate to mountain sports and weather.
For nomads: Expensive but efficient; Zurich and Basel main hubs; strong work culture; co-working prevalent in cities.
Education: Public universities 500-2000/yr; private/international schools 20-40k/yr.
Healthcare: Mandatory insurance; private care very expensive.
pharma-secrecy-bilateral
Swiss pharma framework (Roche + Novartis · world's 4th + 5th largest pharma) + banking-secrecy framework (FINMA + AEoI Automatic Exchange of Information post-2018) + Swiss Bilateral Agreements with EU framework + India-EFTA TEPA February 2024 (in-force 2025 · 18-year framework with $100B Swiss-investment commitment to India).
India implication: Indian-pharma exporters access Swiss + EU markets via India-EFTA TEPA + Swissmedic + EMA framework. $100B Swiss-investment commitment to India over 15 years framework.
Outlook: Swiss pharma + India-EFTA TEPA framework structural through 2030; $100B investment commitment deepens.
European Free Trade Association (EFTA · founded Stockholm 1960 · 4-member · Switzerland + Norway + Iceland + Liechtenstein after UK + Sweden + Denmark + Austria + Portugal departed for EU). EFTA Convention framework + Switzerland Bilateral Agreements with EU framework. India-EFTA TEPA (Trade and Economic Partnership Agreement · signed March 2024 · in-force 2025) with $100B Swiss-investment commitment.
India: India deepens EFTA engagement via Switzerland-anchor + India-EFTA TEPA February 2024 framework + $100B Swiss-investment commitment over 15 years + Swissmedic + EU EMA recognition framework.
HS-30 covers pharma + finished formulations. Swiss pharma-cluster (Basel + Geneva · Roche + Novartis + Lonza + CSL Behring + Bachem · ~$140B+ combined market-cap) anchors global pharma framework. Swissmedic registration framework. India-EFTA TEPA February 2024 + $100B Swiss-investment commitment over 15 years.
India position: Indian-bulk-API + intermediate exporters (Aurobindo + Cipla + Divis Labs + Lupin + Cadila + Dr Reddy's + Suven Pharma) anchor Swiss-pharma supply via Swissmedic + WHO-GMP recognition framework + India-EFTA TEPA framework.
India’s role: Indian-bulk-API + intermediate exporters (Aurobindo + Cipla + Divis Labs + Lupin + Cadila + Dr Reddy's + Suven Pharma) anchor Swiss-pharma supply via Swissmedic + WHO-GMP recognition framework.
Swiss pharma-cluster (Basel + Geneva · Roche + Novartis + Lonza + CSL Behring + Bachem) anchors global pharma framework. Swissmedic registration framework. Indian-bulk-API + intermediate suppliers (Aurobindo + Cipla + Divis Labs + Lupin + Cadila + Dr Reddy's) anchor Swiss-pharma supply.
90 days per 180 (Schengen); varies by nationality
Switzerland uses the Swiss franc (CHF). Capital: Bern.
EFTA member; the India–EFTA TEPA is IN FORCE, tying tariff cuts to a ~$100bn EFTA investment pledge into India over 15 years.
Extremely safe; main risks relate to mountain sports and weather.